Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $124.44 +0.55%
Revenue Growth %: +4.4%
Financial Fact:
Provision for income taxes: 951M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +4.4%
Financial Fact:
Provision for income taxes: 951M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $0.99, $0.04 better than the analyst estimate of $0.95. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.29 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald: Yeztugo Total TRx Down
- Hermès can regain momentum despite China weakness, Jefferies says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
